{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:23:17Z","timestamp":1782915797855,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.vaccine.2010.11.033","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T10:50:46Z","timestamp":1291114246000},"page":"953-959","source":"Crossref","is-referenced-by-count":19,"title":["Safety and protective efficacy of INA-inactivated Venezuelan equine encephalitis virus: Implication in vaccine development"],"prefix":"10.1016","volume":"29","author":[{"given":"Anuj","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paridhi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha K.","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.11.033_bib0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.ento.49.061802.123422","article-title":"Venezuelan equine encephalitis","volume":"49","author":"Weaver","year":"2004","journal-title":"Annu Rev Entomol"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2010.11.033_bib0010","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/030098589803500508","article-title":"Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H\/HeN and BALB\/c mice","volume":"35","author":"Steele","year":"1998","journal-title":"Vet Pathol"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2010.11.033_bib0015","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1574-695X.2007.00319.x","article-title":"Gene expression profiling of nonhuman primates exposed to aerosolized Venezuelan equine encephalitis virus","volume":"51","author":"Koterski","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2010.11.033_bib0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.micro.55.1.235","article-title":"Biological weapons\u2014a primer for microbiologists","volume":"55","author":"Hawley","year":"2001","journal-title":"Annu Rev Microbiol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.11.033_bib0025","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3201\/eid1708.050841","article-title":"Venezuelan equine encephalitis virus transmission and effect on pathogenesis","volume":"12","author":"Smith","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2010.11.033_bib0030","first-page":"33","article-title":"Host range, amplification and arboviral disease emergence","volume":"19","author":"Weaver SC","year":"2005","journal-title":"Arch Virol Suppl"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.11.033_bib0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3201\/eid0901.020136","article-title":"Natural enzootic vectors of Venezuelan equine encephalitis virus, Magdalena Valley, Colombia","volume":"9","author":"Ferro","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2010.11.033_bib0040","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4269\/ajtmh.1976.25.891","article-title":"Experimental infection of North American mammals with epidemic Venezuelan encephalitis virus","volume":"25","author":"Bowen","year":"1976","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2010.11.033_bib0210","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/0300985810372508","article-title":"Review Paper: Pathology of Animal Models of Alphavirus Encephalitis","volume":"47","author":"Steele","year":"2010","journal-title":"Vet Pathol"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2010.11.033_bib0050","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1128\/JVI.77.17.9278-9286.2003","article-title":"Recombinant sindbis\/Venezuelan equine encephalitis virus is highly attenuated and immunogenic","volume":"77","author":"Paessler","year":"2003","journal-title":"J Virol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2010.11.033_bib0055","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1128\/IAI.6.3.339-343.1972","article-title":"Transplacental transmission of Venezuelan equine encephalomyelitis virus in mice","volume":"6","author":"Spertzel","year":"1972","journal-title":"Infect Immun"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2010.11.033_bib0060","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/tera.1420360303","article-title":"TC-83 Venezuelan equine encephalitis vaccine exposure during pregnancy","volume":"36","author":"Casamassima","year":"1987","journal-title":"Teratology"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2010.11.033_bib0065","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4269\/ajtmh.1967.16.762","article-title":"Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man","volume":"16","author":"Alevizatos","year":"1967","journal-title":"Am J Trop Med Hyg"},{"issue":"March (4)","key":"10.1016\/j.vaccine.2010.11.033_bib0070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2010.11.033_bib0075","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jmv.1890380414","article-title":"Venezuelan equine encephalitis-specific immunoglobulin responses: live attenuated TC-83 versus inactivated C-84 vaccine","volume":"38","author":"Engler","year":"1992","journal-title":"J Med Virol"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2010.11.033_bib0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/viro.1995.1458","article-title":"Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1","volume":"212","author":"Davis","year":"1995","journal-title":"Virology"},{"issue":"June (20)","key":"10.1016\/j.vaccine.2010.11.033_bib0085","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.vaccine.2003.09.041","article-title":"Environmental hazard assessment of Venezuelan equine encephalitis virus vaccine candidate strain V3526","volume":"22","author":"Rao","year":"2004","journal-title":"Vaccine"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2010.11.033_bib0090","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.vaccine.2005.06.037","article-title":"Toxicity assessment of Venezuelan Equine Encephalitis virus vaccine candidate strain V3526","volume":"24","author":"Rao","year":"2006","journal-title":"Vaccine"},{"issue":"November","key":"10.1016\/j.vaccine.2010.11.033_bib0095","article-title":"A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV)","author":"Fine","year":"2009","journal-title":"J Virol Methods"},{"issue":"July (26)","key":"10.1016\/j.vaccine.2010.11.033_bib0100","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/S0264-410X(00)00042-6","article-title":"Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate","volume":"18","author":"Hart","year":"2000","journal-title":"Vaccine"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2010.11.033_bib0105","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/S0264-410X(03)00328-1","article-title":"Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models","volume":"21","author":"Pratt","year":"2003","journal-title":"Vaccine"},{"issue":"May (24)","key":"10.1016\/j.vaccine.2010.11.033_bib0110","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.vaccine.2004.12.023","article-title":"Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus","volume":"23","author":"Reed","year":"2005","journal-title":"Vaccine"},{"issue":"June (27\u201328)","key":"10.1016\/j.vaccine.2010.11.033_bib0115","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1016\/j.vaccine.2008.04.044","article-title":"Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates","volume":"26","author":"Fine","year":"2008","journal-title":"Vaccine"},{"issue":"November (49)","key":"10.1016\/j.vaccine.2010.11.033_bib0120","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1016\/j.vaccine.2009.09.013","article-title":"Telemetric analysis to detect febrile responses in mice following vaccination with a live-attenuated virus vaccine","volume":"27","author":"Martin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.033_bib0125","series-title":"Safety of an attenuated Venezuelan equine encephalitis virus (VEEV) vaccine in humans","author":"Holley","year":"2008"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2010.11.033_bib0130","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbrc.2007.04.115","article-title":"Complete inactivation of Venezuelan equine encephalitis virus by 1,5-iodonaphthylazide","volume":"358","author":"Sharma","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"July (4353)","key":"10.1016\/j.vaccine.2010.11.033_bib0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1126\/science.663661","article-title":"Red cell membrane glycophorin labeling from within the lipid bilayer","volume":"201","author":"Kahane","year":"1978","journal-title":"Science"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2010.11.033_bib0140","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1073\/pnas.84.17.6103","article-title":"Selective labeling of proteins in biological systems by photosensitization of 5-iodonaphthalene-1-azide","volume":"84","author":"Raviv","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2010.11.033_bib0145","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1021\/bi00601a020","article-title":"5-[125I]Iodonaphthyl azide, a reagent to determine the penetration of proteins into the lipid bilayer of biological membranes","volume":"17","author":"Bercovici","year":"1978","journal-title":"Biochemistry"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2010.11.033_bib0150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/bi00298a016","article-title":"Selective photoinduced uncoupling of the response of adenylate cyclase to gonadotropins by 5-iodonaphthyl 1-azide","volume":"23","author":"Raviv","year":"1984","journal-title":"Biochemistry"},{"issue":"October (19)","key":"10.1016\/j.vaccine.2010.11.033_bib0155","doi-asserted-by":"crossref","first-page":"12394","DOI":"10.1128\/JVI.79.19.12394-12400.2005","article-title":"Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope","volume":"79","author":"Raviv","year":"2005","journal-title":"J Virol"},{"issue":"November (Suppl. 2)","key":"10.1016\/j.vaccine.2010.11.033_bib0160","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1086\/520605","article-title":"Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent","volume":"196","author":"Warfield","year":"2007","journal-title":"J Infect Dis"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2010.11.033_bib0165","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1128\/JVI.02233-07","article-title":"Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicity","volume":"82","author":"Raviv","year":"2008","journal-title":"J Virol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.11.033_bib0170","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4269\/ajtmh.2008.78.328","article-title":"Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection","volume":"78","author":"Turell","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"August (Pt 8)","key":"10.1016\/j.vaccine.2010.11.033_bib0175","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1099\/vir.0.010280-0","article-title":"Oligonucleotide array analysis of Toll-like receptors and associated signalling genes in Venezuelan equine encephalitis virus-infected mouse brain","volume":"90","author":"Sharma","year":"2009","journal-title":"J Gen Virol"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2010.11.033_bib0180","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4049\/jimmunol.73.4.244","article-title":"Antibody response of suckling mice to mumps virus. I. Immune response following immunization with mumps virus vaccine","volume":"73","author":"Overman","year":"1954","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.11.033_bib0185","first-page":"31","article-title":"Age-dependent susceptibility to fatal encephalitis: alphavirus infection of neurons","volume":"9","author":"Griffin","year":"1994","journal-title":"Arch Virol Suppl"},{"issue":"August (1)","key":"10.1016\/j.vaccine.2010.11.033_bib0190","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0264-410X(00)00113-4","article-title":"Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus","volume":"19","author":"Pushko","year":"2000","journal-title":"Vaccine"},{"issue":"October","key":"10.1016\/j.vaccine.2010.11.033_bib0195","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc15b01s00","article-title":"Sindbis virus: propagation, quantification, and storage","author":"Hernandez","year":"2005","journal-title":"Curr Protoc Microbiol"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2010.11.033_bib0200","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1021\/bi701920f","article-title":"Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane","volume":"47","author":"Viard","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2010.11.033_bib0205","doi-asserted-by":"crossref","unstructured":"Martin SS, Bakken RR, Lind CM, Garcia P, Jenkins E, Glass PJ, et al. Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB. Vaccine 2010;28(January (4)):1031\u201340.","DOI":"10.1016\/j.vaccine.2009.10.126"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10016671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10016671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T09:40:28Z","timestamp":1685871628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10016671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0264410X10016671"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.11.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}